Transient Protein Expression Market Set to Hit US$ 1.32 Billion by 2031
The worldwide market is supported by growing investment in monoclonal antibodies, bispecifics, and other complex biologics. Transient systems shorten development timelines, making them well suited to early-stage screening and candidate selection. Academic institutions, biotech firms, and contract research organizations are the main buyers. Batch-to-batch variability and transfection costs pose...
0 Commentaires 0 Parts 8 Vue 0 Aperçu
social art-inpa https://social.art-inpa.com